ONE-WAYOngoing theme · still written in the latest filings
Improving Out-Licensing Profitability Through In-House Development Beyond the Preclinical Stage
A business model that increases profitability and revenue from out-licensing by advancing development in-house from the preclinical stage onward, rather than relying on early-stage out-licensing.
Companies6How many companies write about this.
Threads6One company can carry more than one thread here.